Follow The Filings

IONS position history

The shares of Ionis Pharmaceuticals (IONS) that FARALLON CAPITAL MANAGEMENT, L.L.C. reported in each quarter’s 13F.

Equity, COM

Shares held by quarter

New Add Reduce Exit

  1. 2023 Q2: 5,000 shares, $205K, <0.01% of portfolio, New
  2. 2023 Q3: 727,000 shares, $33M, 0.17% of portfolio, Add +14440.0%
  3. 2023 Q4: 1,555,020 shares, $79M, 0.39% of portfolio, Add +113.9%
  4. 2024 Q1: 1,468,000 shares, $64M, 0.29% of portfolio, Reduce −5.6%
  5. 2024 Q2: 4,800 shares, $229K, <0.01% of portfolio, Reduce −99.7%
  6. 2024 Q3: not held, Exit
  7. 2024 Q4: not held
  8. 2025 Q1: not held
  9. 2025 Q2: not held
  10. 2025 Q3: 9,600 shares, $628K, <0.01% of portfolio, New
  11. 2025 Q4: 4,800 shares, $380K, <0.01% of portfolio, Reduce −50.0%
  12. 2026 Q1: 4,800 shares, $360K, <0.01% of portfolio
  13. 2026 Q2: not held, Exit
Holdings date Value % of holdings Shares Filing date All 13F holders